VOXEA Information

VOXEA is building the voice intelligence layer for healthcare AI — turning everyday patient voice into clinical-grade intelligence for earlier detection, risk triage and continuous monitoring. Already regulatory-cleared and generating ~$2M in revenue across three healthcare systems in Singapore, VOXEA is now scaling into the U.S. through an expedited FDA pathway targeting ~10 cleared and reimbursable conditions over the next two years, with Microsoft as a major distribution partner. Proven: Regulatory clearance, real-world deployment and ~$2M revenue across 3 healthcare systems Backed: Singapore’s Ministry of Health and Temasek U.S. scale: Expedited FDA pathway targeting ~10 cleared and reimbursable conditions in 2 years Distribution: Microsoft as a major distribution partner Built by the people who helped define healthcare AI: the VP who pioneered the ambient clinical intelligence category, the engineer who built Microsoft 365’s compliance platform, and a Mayo physician-scientist with 90+ publications in voice and cardiovascular AI